Studies on plant secondary metabolites have been increasing over the last 5
0 years. These molecules are known to play a major role in the adaptation o
f plants to their environment, but also represent an important source of ac
tive pharmaceuticals. Plant cell culture technologies were introduced at th
e end of the 1960s as a possible tool for both studying and producing plant
secondary metabolites. Different strategies, using in vitro systems, have
been extensively studied with the objective of improving the production of
secondary plant compounds. Undifferentiated cell cultures have been mainly
studied, but a large interest has also been shown in hairy roots and other
organ cultures. Specific processes have been designed to meet the requireme
nts of plant cell and organ cultures in bioreactors. Despite all of these e
fforts of the last 30 years, plant biotechnologies have led to very few com
mercial successes for the production of valuable secondary compounds. Compa
red to other biotechnological fields such as microorganisms or mammalian ce
ll cultures, this can be explained by a lack of basic knowledge about biosy
nthetic pathways, or insufficiently adapted reactor facilities. More recent
ly, the emergence of recombinant DNA technology has opened a new field with
the possibility of directly modifying the expression of genes related to b
iosyntheses. It is now possible to manipulate the pathways that lead to sec
ondary plant compounds. Many research projects are now currently being carr
ied out and should give a promising future for plant metabolic engineering.
(C) 1999 Elsevier Science Ireland Ltd. All rights reserved.